Generis Capital Partners

Summary

Generis Capital Partners appeared to be the VC, which was created in 2009. The leading representative office of defined VC is situated in the Paris. The fund was located in Europe if to be more exact in France.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Generis Capital Partners, startups are often financed by Piton Capital, Earlybird Venture Capital, DN Capital. The meaningful sponsors for the fund in investment in the same round are Piton Capital, Earlybird Venture Capital, DN Capital. In the next rounds fund is usually obtained by Piton Capital, Earlybird Venture Capital, DN Capital.

The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the various public portfolio startups of the fund, we may underline WeQ, Finexkap, EyeGate Pharmaceuticals For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the most popular fund investment industries, there are Health Care, Pharmaceutical. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

The increased amount of exits for fund were in 2018. The usual things for fund are deals in the range of 5 - 10 millions dollars. This Generis Capital Partners works on 5 percentage points less the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 21 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity.

The fund was created by Thibaut de Roux. The overall number of key employees were 6.